Study to Evaluate Long Term Immunogenicity up to 10 Years After the First Booster Immunization With Tick Borne Encephalitis Vaccine in Adults Who Received 1 of 3 Different Primary Vaccination Schedules
Clinical trial NCT01562444 · COMPLETED
Trial details
- NCT number
- NCT01562444
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-08
- Primary completion
- 2016-09-30
- Enrollment
- 206
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.